Lung cancer remains the leading cause of cancer-related mortality in both men and women
in the US and worldwide. Non-small cell lung cancer is the most common variety accounting …

This review will describe the global patterns and trends of colorectal cancer survival, using
data from the population-based studies or cancer registration. We performed a systematic …

Introduction In the KEYNOTE-010 study, pembrolizumab improved overall survival (OS)
versus docetaxel in patients with previously treated, advanced NSCLC with programmed …

PURPOSE Phosphatidylinositol-3-kinase (PI3K) inhibitors have shown activity in relapsed or
refractory (R/R) indolent non-Hodgkin lymphoma (iNHL). PI3K inhibitors have been …

Artificial intelligence (AI)‐based systems applied to histopathology whole‐slide images have
the potential to improve patient care through mitigation of challenges posed by diagnostic …

PURPOSE Update all preceding ASCO guidelines on initial hormonal management of
noncastrate advanced, recurrent, or metastatic prostate cancer. METHODS The Expert …

Background Approximately 25% of thyroid nodule fine‐needle aspirates (FNAs) have
cytology that is indeterminate for malignant disease. Accurate risk stratification of these …

As lung cancer remains the leading cause of cancer deaths globally, characterizing the
tumor molecular profiles is crucial to tailoring treatments for individuals at advanced stages …

Despite therapeutic advancements, oral cavity squamous cell carcinoma (OCSCC) remains
a difficult disease to treat. Systemic platinum-based chemotherapy often leads to dose …

Purpose: This phase II study tested granulocyte-macrophage colony-stimulating factor (GM-
CSF)-allogeneic pancreatic tumor cells (GVAX) and ipilimumab in metastatic pancreatic …